Google fires four employees over data sharing

Google fired four staffers for sharing sensitive information, some of whom were involved in recent protests over leadership, CNBC reported.

Four workers were fired because an investigation by the company concluded they engaged in wrongdoing, according to a memo from Google’s Security and Investigations team, which also stated the employees searched for, accessed and distributed business information outside the scope of their jobs.

“The company said the employees shared sensitive information, including medical appointments and other meetings," CNBC reported.

At least two of the four fired employees are employee activists.

The report comes at a time when Google is under scrutiny over its newly revealed patient data sharing partnership with Ascension, the nation’s largest Catholic health system. That project, which is called Project Nightingale and was revealed by The Wall Street Journal, gives Google access to the health information of tens of millions of members at Ascension.

The revelation of the project between Google and Ascension put both companies on the defence of their partnership amid cries of privacy concerns and a request from a Congressional committee to provide more information on patient protections.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.